Pishas and Lessnick concluded that SP-2509 resistance in Ewing sarcoma was not fully reversible or driven by direct mutation in KDM1A and, therefore, may have been due to other epigenetic mechanisms [47]. The gene discussed is KDM1A; the disease is Ewing sarcoma.